Online first
Short communication
Published online: 2024-07-22
Cardiovascular risk factors and cardiovascular diseases in patients with newly diagnosed most common cancers in Poland. Preliminary data from the CONNECT-POL registry.
Abstract
Not available
References
- Beasley GS, Towbin JA. Acquired and modifiable cardiovascular risk factors in patients treated for cancer. J Thromb Thrombolysis. 2021; 51(4): 846–853.
- Chlabicz M, Jamiołkowski J, Sowa P, et al. Multimorbidity patterns in the urban population in poland. J Clin Med. 2023; 12(18).
- Niklas A, Marcinkowska J, Kozela M, et al. Blood pressure and cholesterol control in patients with hypertension and hypercholesterolemia: the results from the Polish multicenter national health survey WOBASZ II. Pol Arch Intern Med. 2019; 129(12): 864–873.
- Lelonek M, Pawlak A, Nessler J et al. Niewydolność serca w Polsce 2014–2021. Raport Asocjacji Niewydolności Serca Polskiego Towarzystwa Kardiologicznego. niewydolnosc-serca.pl (06.02.2024).
- Nowakowska M, Płońska-Gościniak E, Szyszka A, et al. Cardiovascular risk factors among cancer patients qualified for systemic treatment. Analysis of a cardiovascular disease-free cohort from the Polish multicentre study ONCOECHO. Arch Med Sci. 2020; 16(6): 1295–1303.
- Al-Kindi SG, Oliveira GH. Prevalence of preexisting cardiovascular disease in patients with different types of cancer: the unmet need for onco-cardiology. Mayo Clin Proc. 2016; 91(1): 81–83.
- Battisti NM, Welch CA, Sweeting M, et al. Prevalence of cardiovascular disease in patients with potentially curable malignancies: a national registry dataset analysis. JACC CardioOncol. 2022; 4(2): 238–253.
- Caro-Codón J, López-Fernández T, Álvarez-Ortega C, et al. CARDIOTOX registry investigators. Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry. Eur J Prev Cardiol. 2022; 29(6): 859–868.
